Recent additions may not be included but will usually appear in 24 hrs or less.
| Rational | Source |
|---|---|
|
Red ginseng has stronger anti-aging effects compared to ginseng possibly due to its regulation of oxidative stress and the gut microbiota. β
Go to Publication β
Phytomedicine : international journal of phytotherapy and phytopharmacology (Phytomedicine ) Vol: 93 Issue Pages: 153772 Pub: 2021 Dec Epub: 2021 Sep 23 Authors Peng X , Hao M , Zhao Y , Cai Y , Chen X , Chen H , Zhang Y , Dong L , Liu X , Ding C , Liu W , Yang M , Luo Y , |
|
|
Panax quinquefolius Polysaccharides Ameliorate Antibiotic-Associated Diarrhoea Induced by Lincomycin Hydrochloride in Rats via the MAPK Signaling Pathways. β
Go to Publication β
Journal of immunology research (J Immunol Res ) Vol: 2022 Issue Pages: 4126273 Pub: 2022 Epub: 2022 Mar 19 Authors Ren DD , Li SS , Lin HM , Xia YS , Li ZM , Bo PP , Mu R , Zhao LJ , Sun YS , |
|
|
Polysaccharide from Panax japonicus C.A. Mey prevents non-alcoholic fatty liver disease development based on regulating liver metabolism and gut microbiota in mice. β
Go to Publication β
International journal of biological macromolecules (Int J Biol Macromol ) Vol: 260 Issue Pt 1 Pages: 129430 Pub: 2024 Mar Epub: 2024 Jan 14 Authors Wu Y , Yin W , Hao P , Chen Y , Yu L , Yu X , Wu Y , Li X , Wang W , Zhou H , Yuan Y , Quan X , Yu Y , Hu B , Chen S , Zhou Z , Sun W , |
|
|
Study on the Therapeutic Effects and Mechanisms of Gintonin in Irritable Bowel Syndrome and Its Relationship with TRPV1, TRPV4, and NaV1.5. β
Go to Publication β
Pharmaceuticals (Basel, Switzerland) (Pharmaceuticals (Basel) ) Vol: 17 Issue 9 Pages: Pub: 2024 Sep 4 Epub: 2024 Sep 4 Authors Choi NR , Ko SJ , Nam JH , Choi WG , Lee JH , Nah SY , Park JW , Kim BJ , |
|
|
Study on the Therapeutic Effects and Mechanisms of Gintonin in Irritable Bowel Syndrome and Its Relationship with TRPV1, TRPV4, and NaV1.5. β
Go to Publication β
Pharmaceuticals (Basel, Switzerland) (Pharmaceuticals (Basel) ) Vol: 17 Issue 9 Pages: Pub: 2024 Sep 4 Epub: 2024 Sep 4 Authors Choi NR , Ko SJ , Nam JH , Choi WG , Lee JH , Nah SY , Park JW , Kim BJ , |
|
|
Study on the Therapeutic Effects and Mechanisms of Gintonin in Irritable Bowel Syndrome and Its Relationship with TRPV1, TRPV4, and NaV1.5. β
Go to Publication β
Pharmaceuticals (Basel, Switzerland) (Pharmaceuticals (Basel) ) Vol: 17 Issue 9 Pages: Pub: 2024 Sep 4 Epub: 2024 Sep 4 Authors Choi NR , Ko SJ , Nam JH , Choi WG , Lee JH , Nah SY , Park JW , Kim BJ , |
|
|
Ameliorative effect of total ginsenosides from heat-treated fresh ginseng against cyclophosphamide-induced liver injury in mice. β
Go to Publication β
Current research in food science (Curr Res Food Sci ) Vol: 8 Issue Pages: 100734 Pub: 2024 Epub: 2024 Apr 17 Authors Tang P , Ren G , Zou H , Liu S , Zhang J , Ai Z , Hu Y , Cui L , Nan B , Zhang Z , Wang Y , |
|
|
Effect of Korea red ginseng on nonalcoholic fatty liver disease: an association of gut microbiota with liver function. β
Go to Publication β
Journal of ginseng research (J Ginseng Res ) Vol: 45 Issue 2 Pages: 316-324 Pub: 2021 Mar Epub: 2020 Jul 16 Authors Hong JT , Lee MJ , Yoon SJ , Shin SP , Bang CS , Baik GH , Kim DJ , Youn GS , Shin MJ , Ham YL , Suk KT , Kim BS , |
|
|
Effect of Korea red ginseng on nonalcoholic fatty liver disease: an association of gut microbiota with liver function. β
Go to Publication β
Journal of ginseng research (J Ginseng Res ) Vol: 45 Issue 2 Pages: 316-324 Pub: 2021 Mar Epub: 2020 Jul 16 Authors Hong JT , Lee MJ , Yoon SJ , Shin SP , Bang CS , Baik GH , Kim DJ , Youn GS , Shin MJ , Ham YL , Suk KT , Kim BS , |
|
|
Effect of Korea red ginseng on nonalcoholic fatty liver disease: an association of gut microbiota with liver function. β
Go to Publication β
Journal of ginseng research (J Ginseng Res ) Vol: 45 Issue 2 Pages: 316-324 Pub: 2021 Mar Epub: 2020 Jul 16 Authors Hong JT , Lee MJ , Yoon SJ , Shin SP , Bang CS , Baik GH , Kim DJ , Youn GS , Shin MJ , Ham YL , Suk KT , Kim BS , |
|
|
Ginsenosides From Panax ginseng Improves Hepatic Lipid Metabolism Disorders in HFD-Fed Rats by Regulating Gut Microbiota and Cholesterol Metabolism Signaling Pathways. β
Go to Publication β
Phytotherapy research : PTR (Phytother Res ) Vol: Issue Pages: Pub: 2024 Dec 11 Epub: 2024 Dec 11 Authors Zhu Y , Zhang KX , Bu QY , Song SX , Chen Y , Zou H , You XY , Zhao GP , |
|
|
Differences in Intestinal Metabolism of Ginseng Between Normal and Immunosuppressed Rats. β
Go to Publication β
European journal of drug metabolism and pharmacokinetics (Eur J Drug Metab Pharmacokinet ) Vol: 46 Issue 1 Pages: 93-104 Pub: 2021 Jan Epub: Authors Zhu JH , Xu JD , Zhou SS , Zhang XY , Zhou J , Kong M , Mao Q , Zhu H , Li SL , |
|
|
Differences in Intestinal Metabolism of Ginseng Between Normal and Immunosuppressed Rats. β
Go to Publication β
European journal of drug metabolism and pharmacokinetics (Eur J Drug Metab Pharmacokinet ) Vol: 46 Issue 1 Pages: 93-104 Pub: 2021 Jan Epub: Authors Zhu JH , Xu JD , Zhou SS , Zhang XY , Zhou J , Kong M , Mao Q , Zhu H , Li SL , |
|
|
Differences in Intestinal Metabolism of Ginseng Between Normal and Immunosuppressed Rats. β
Go to Publication β
European journal of drug metabolism and pharmacokinetics (Eur J Drug Metab Pharmacokinet ) Vol: 46 Issue 1 Pages: 93-104 Pub: 2021 Jan Epub: Authors Zhu JH , Xu JD , Zhou SS , Zhang XY , Zhou J , Kong M , Mao Q , Zhu H , Li SL , |
|
|
Differences in Intestinal Metabolism of Ginseng Between Normal and Immunosuppressed Rats. β
Go to Publication β
European journal of drug metabolism and pharmacokinetics (Eur J Drug Metab Pharmacokinet ) Vol: 46 Issue 1 Pages: 93-104 Pub: 2021 Jan Epub: Authors Zhu JH , Xu JD , Zhou SS , Zhang XY , Zhou J , Kong M , Mao Q , Zhu H , Li SL , |
All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.
Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance. Special thanks to Oliver Luk, B.Sc. (Biology) from BiomeSight for spot checking the coding of data from the US National Library of Medicine
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 Β§β―1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.
